The IN.PACT SFA Clinical Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery Using the IN.PACT Admiral™ Drug-Eluting Balloon in a Chinese Patient Population

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 143 participants.

Also called NCT02118532

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 143 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02118532
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02118532. Allocation not applicable; no masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2016-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The IN.PACT SFA Clinical Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery Using the IN.PACT Admiral™ Drug-Eluting Balloon in a Chinese Patient Population
Condition
Atherosclerosis
Intervention (Device)
IN.PACT Admiral Paclitaxel-Eluting Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter
Lead sponsor
Medtronic Endovascular (class: industry)

Record details

Record id
cardio:ct-nct02118532
Content hash
874b536fcb39542f19be3d34c421360bb4a0f4cd49afa55f1969635effaaf086